CDRM Study: Computer-assisted diabetes risk management - evaluation of a medical care approach to support secondary and tertiary prevention of diabetes mellitus and its complications

CDRM Study: Computer-assisted diabetes risk management - evaluation of a medical care approach to support secondary and tertiary prevention of diabetes mellitus and its complications - CDRM Studie

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000056

Enrollment

400

Registered

2008-12-08

Start date

2009-03-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes E11

Interventions

Group 1: Using the study design, we will determine the effects of a computer-assisted, multifaceted diabetes risk management system. It consists of a combination of several telematic instruments used

Eligibility

Sex/Gender

All

Age

40 Years to 68 Years

Inclusion criteria

Inclusion criteria: Diagnosed with Type 2 Diabetes Mellitus Older than 40 years at the time of diabetes diagnosis Participating in the Diabetes RSAV-DMP (German state health insurance DMP)

Exclusion criteria

Exclusion criteria: Pregnant Dementia, psychoses, or other illness that would hinder compliance Serious illness such as: cancer, immune deficiency syndrome (HIV), genetic lipid disorder (e.g. autosomal dominant familial hypercholesteremia) Malabsorption syndromes such as colitis and Morbus Crohns disease. Bed-ridden or required supportive care Cardiac insufficiency > NYHA class II Chronic metabolic storage illnesses such as Morbus Wilson or Amyloidosis. Endocrinologic diseases with elevated anti-insulin hormone (e.g. hyperthyreosis, pheochromocytoma, acromegaly. Chronic inflammatory diseases. Chronic therapy with corticosteroids, diazoxide. Pancreatic Diabetes mellitus (e.g. alcoholism, chronic pancreatitis, pancreatic resection) Any illness that would prevent the active involvement of the patient in the present study

Design outcomes

Primary

Measure	Time frame
HbA1c and other metabolic parameters at last observation, incidence of typical diabetes complications and changes of complication risk profile during observation time	—

Secondary

Measure	Time frame
patients reported outcomes (EuroQol, DTSQ) \|\| Impact of the intervention on process and utilisation of care \|\| impact of the intervention on patient knowledge and behaviour \|\| Impact of the intervention on clinical effectiveness	—

Countries

Germany

Contacts

Public ContactUlrich Otto Mueller

Philipps-Universität Marburg Fachbereich Medizin Institut für Med. Soziologie und Sozialmedizin

mueller2@staff.uni-marburg.de+49 (0) 6421 286 6244

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026